MB MAINLINE BIOSCIENCES Trademark

Trademark Overview


On Friday, November 18, 2022, a trademark application was filed for MB MAINLINE BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the MB MAINLINE BIOSCIENCES trademark a serial number of 97683356. The federal status of this trademark filing is REGISTERED as of Tuesday, April 21, 2026. This trademark is owned by Mainline Biosciences (Shanghai) Co., Ltd.. The MB MAINLINE BIOSCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
mb mainline biosciences

General Information


Serial Number97683356
Word MarkMB MAINLINE BIOSCIENCES
Filing DateFriday, November 18, 2022
Status700 - REGISTERED
Status DateTuesday, April 21, 2026
Registration Number8223257
Registration DateTuesday, April 21, 2026
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements


Description of MarkThe mark consists of a stylized blue "M" to the left of a stylized light blue "B" above the stylized blue wording "MAINLINE BIOSCIENCE".
NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesPharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
Indication of Colors claimedThe color(s) blue and light blue is/are claimed as a feature of the mark.
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2018
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/01/2018

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 9, 2022
Primary Code005
First Use Anywhere DateSaturday, February 1, 2025
First Use In Commerce DateSaturday, February 1, 2025

Trademark Owner History


Party NameMainline Biosciences (Shanghai) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLingang, Shanghai 201413
CN

Party NameMainline Biosciences (Shanghai) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLingang, Shanghai 201413
CN

Party NameMainline Biosciences (Shanghai) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLingang, Shanghai 201413
CN

Trademark Events


Event DateEvent Description
Tuesday, November 22, 2022NEW APPLICATION ENTERED
Friday, December 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Friday, September 1, 2023NON-FINAL ACTION WRITTEN
Friday, September 1, 2023NON-FINAL ACTION E-MAILED
Friday, September 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 11, 2024NON-FINAL ACTION WRITTEN
Thursday, January 11, 2024NON-FINAL ACTION E-MAILED
Thursday, January 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 11, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, April 11, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, July 17, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 17, 2024PETITION TO REVIVE-GRANTED
Wednesday, July 17, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, July 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 24, 2024ASSIGNED TO LIE
Thursday, October 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 13, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, October 13, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 13, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, October 13, 2025PETITION TO REVIVE-GRANTED
Monday, October 13, 2025NOTICE OF REVIVAL - E-MAILED
Monday, October 13, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, October 13, 2025TEAS STATEMENT OF USE RECEIVED
Monday, October 13, 2025USE AMENDMENT FILED
Wednesday, April 1, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 1, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 1, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 21, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, April 21, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED